Results for
EPO Boards of Appeal
EPO pharma case law trends 2025: Clinical inventions
Reviewed by
Dr Rose Hughes
on
Monday, November 24, 2025
Rating:
5
EPO pharma case law trends 2025: Antibodies and biologics
Reviewed by
Dr Rose Hughes
on
Monday, November 17, 2025
Rating:
5
Never Too Late: If you missed the IPKat last week!
Reviewed by
Asude Sena Moya
on
Tuesday, March 25, 2025
Rating:
5
Excluding a technical feature is not inventive without evidence of a technical effect (T 1865/22)
Reviewed by
Dr Rose Hughes
on
Friday, March 21, 2025
Rating:
5
Functional claims for pharmaceutical formulations: Validity versus enforcement (T 2130/22)
Reviewed by
Dr Rose Hughes
on
Friday, January 24, 2025
Rating:
5
The morality (and patentability) of inventions derived by immoral means (T 2510/18)
Reviewed by
Dr Rose Hughes
on
Thursday, October 31, 2024
Rating:
5
Stretching the cheese: Contradictory evidence for a purported technical effect relied on for inventive step (T 0629/22)
Reviewed by
Dr Rose Hughes
on
Monday, May 13, 2024
Rating:
5